BIMEKIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 07:58:44 GMT 2023` Edited by `admin` on `Sat Dec 16 07:58:44 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	09495UIM6V
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

BIMEKIZUMAB

Official Name

English

UCB-4940

Code

English

UCB4940

Code

English

Bimekizumab [WHO-DD]

Common Name

English

BIMEKIZUMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A) AND HOMO SAPIENS IL17F (INTERLEUKIN 17F)), HUMANIZED MONOCLONAL ANTIBODY

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A) AND HOMO SAPIENS IL17F (INTERLEUKIN 17F)), HUMANIZED MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN (1-455) (HUMANIZED VH (HOMO SAPIENS IGHV3-7*01 (88.70%) -(IGHD)-IGHJ1*01) (8.8.18) (1-125)-HOM

Common Name

English

BIMEKIZUMAB [JAN]

Common Name

English

bimekizumab [INN]

Common Name

English

Code System Code Type Description

CAS

1418205-77-2

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

WIKIPEDIA

Bimekizumab

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

SMS_ID

100000169021

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

DRUG BANK

DB12917

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

USAN

GH-24

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

INN

9878

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

NCI_THESAURUS

C171829

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

EVMPD

SUB182636

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

FDA UNII

09495UIM6V

Created by admin on Sat Dec 16 07:58:44 GMT 2023 , Edited by admin on Sat Dec 16 07:58:44 GMT 2023

PRIMARY

From	To
1_22	1_96
1_152	1_208
1_269	1_329
1_375	1_433
2_22	2_96
2_152	2_208
2_269	2_329
2_375	2_433
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194
1_228	3_214
2_228	4_214
1_234	2_234
1_237	2_237

Glycosylation Link Type	Site
N	1_305
N	2_305

Related Record Type Details

Bimekizumab-BKZX

SUB_CONCEPT->SUBSTANCE

Amount:


					R44E6C7B6J

INTERLEUKIN-17A

TARGET -> INHIBITOR

Related Record Type Details


					09495UIM6V

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL